Article Details
Retrieved on: 2024-03-17 22:43:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Proteomics International Laboratories Ltd's efforts to commercialize PromarkerD in the U.S. for diabetic kidney disease and other diagnostic tests, highlighting the field of biotech, which encompasses genomics, omics, and proteomics.
Article found on: www.abnnewswire.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here